UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Dover Advisors LLC

Dover Advisors LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 5,995 shares of the healthcare conglomerate’s stock after selling 583 shares during the quarter. UnitedHealth Group makes up about 1.7% of Dover Advisors LLC’s portfolio, making the stock its 9th largest holding. Dover Advisors LLC’s holdings in UnitedHealth Group were worth $3,033,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. M&T Bank Corp lifted its position in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after acquiring an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares during the period. Benjamin Edwards Inc. grew its stake in shares of UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new position in UnitedHealth Group during the 3rd quarter worth approximately $21,165,000. Finally, Signal Advisors Wealth LLC grew its stake in UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the subject of several research reports. Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Down 7.3 %

NYSE:UNH opened at $465.58 on Monday. The company has a market cap of $428.46 billion, a P/E ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock’s fifty day moving average price is $519.27 and its two-hundred day moving average price is $560.44.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.83 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.